Every person deserves access to high quality healthcare, no matter who they are or where they live! Read more from our partners at GSK 👇

Today it’s National Youth HIV & AIDS awareness day.

In 2023, The Breakthrough Partnership; Aidsfonds, UNICEF, Elizabeth Glaser Pediatric AIDS Foundation, PATA, and Positive Action, expanded programming in Cameroon and Tanzania to help reach our goal of ending paediatric AIDS.

If we're going to end the HIV epidemic, we need to focus on treatment AND prevention!

We’re disappointed by the Uganda Constitutional Court ruling which upholds most elements of the #AHA . We are committed to ensuring that every person, regardless of who they are or where they live, has access to healthcare services without fear.

viivhealthcare.com/hiv-news-and-m…

U=U is an impactful abbreviation for Undetectable = Untransmittable, which means that if a person living with #HIV is on effective medication and has an undetectable viral load, they cannot transmit HIV through sex.

Find out more! viivhealthcare.com/living-with-hi…

#WeWontStop

Stigma should not stand in the way of education. When it comes to #chemsex , there is much to learn so that everyone can be aware of how to pursue pleasure safely.

Learn more about chemsex and #HIVPrevention on Science On The Sofa: youtu.be/myjXoVPSc6I?si…

📢 U=U 📢

Ending the #HIV epidemic requires the HIV community to work together. Learn more about how funding through our Positive Action programme enabled local community groups to tackle HIV & support more than 500k people living or affected by HIV in 2023. #WeWontStop

Thrilled to announce our continued partnership with Oliver Zeffman and GAY TIMES for an expanded Classical Pride! 🎺🌈 All proceeds support LGBTQ+ charities. Join us in celebrating and supporting their impact. Find our more and get your TICKETS here! classicalpride.uk

#DYK that real world evidence (RWE) can help to show how people living with #HIV around the world respond to treatments?

Check out how we're using RWE to tackle underrepresentation in HIV research. 👇

#WeWontStop

Historically, Black women have been overlooked and ignored when it comes to #HIV . Our Risks to Reasons initiative aims to reframe and refocus HIV prevention and care for Black women. Read more via Dallas Morning News: bit.ly/3VdHvLH

#NWGHAAD

On #IWD , we are spotlighting ambassadors the HER Voice Fund, a partnership that reaches 50,000 adolescent girls and young women living with #HIV each year: youtu.be/baDlVs85U3w

#WeWontStop #InspireInclusion

The Global Fund, Y+ Global

Today is International Women's Day. Let's celebrate the strength of every woman and champion inclusion and equality. We must continue to protect women's and girls’ health and rights and ensure their health and well-being are safeguarded. 💪🚺 #IWD2024 #InspireInclusion

#News for #investors and #media Today at #CROI2024 , our presentation set the stage for a next generation of medicines in #HIV . See more: viivhealthcare.com

We won't stop studying our medicines to better understand how they are experienced by diverse groups of people living with HIV.

Find out more about our presence at #CROI2024 : viivhealthcare.com/hiv-news-and-m…

#WeWontStop #RealWorldEvidence #RWE

#News We are proud to honour the legacy of Dawn K. Smith, a leader and mentor to many in HIV prevention, by announcing a fellowship from American Academy of HIV Medicine to train the next wave of professionals working to end the epidemic. Learn more: viivhealthcare.com

#News for #Investors and #Media : Today at #CROI2024 , our presentation set the stage for a next generation of medicines in #HIV . See more: viivhealthcare.com

Full House at Opening Ceremony #CROI2024

#Investors and #Media
We’ve published our 2023 #GSKAnnualReport and
#ESG Performance Report. Learn how we are uniting science, technology and talent to get ahead of disease together for health impact, shareholder returns and thriving people

More: gsk.to/3IlY40g

#Investors and #Media :
Read our cautionary statement regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures in our 2023 Annual Report #GSKAnnualReport .

gsk.to/49WPHnB